These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9776137)

  • 21. In vivo binding of [125I]RTI-55 to dopamine transporters: pharmacology and regional distribution with autoradiography.
    Cline EJ; Scheffel U; Boja JW; Mitchell WM; Carroll FI; Abraham P; Lewin AH; Kuhar MJ
    Synapse; 1992 Sep; 12(1):37-46. PubMed ID: 1411962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CoMFA study of novel phenyl ring-substituted 3alpha-(diphenylmethoxy)tropane analogues at the dopamine transporter.
    Newman AH; Izenwasser S; Robarge MJ; Kline RH
    J Med Chem; 1999 Sep; 42(18):3502-9. PubMed ID: 10479283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The zitter mutant rat exhibits loss of D3 receptors with degeneration of the dopamine system.
    Joyce JN; Yoshimoto K; Ueda S
    Neuroreport; 2000 Jul; 11(10):2173-5. PubMed ID: 10923665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.
    Villemagne VL; Rothman RB; Yokoi F; Rice KC; Matecka D; Dannals RF; Wong DF
    Synapse; 1999 Apr; 32(1):44-50. PubMed ID: 10188637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between injection duration, transporter occupancy and reinforcing strength of cocaine.
    Woolverton WL; Wang Z
    Eur J Pharmacol; 2004 Feb; 486(3):251-7. PubMed ID: 14985046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex.
    Zhu J; Apparsundaram S; Bardo MT; Dwoskin LP
    J Neurochem; 2005 Jun; 93(6):1434-43. PubMed ID: 15935059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex.
    Carboni E; Silvagni A; Vacca C; Di Chiara G
    J Neurochem; 2006 Jan; 96(2):473-81. PubMed ID: 16336224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opposing effects of clomipramine on [125I]RTI-55 and [3H]N-methylspiperone binding in mouse striatum: important role of other factors than endogenous dopamine?
    Inoue O; Kobayashi K; Hosoi R; Gee A
    Synapse; 1998 Nov; 30(3):338-40. PubMed ID: 9776138
    [No Abstract]   [Full Text] [Related]  

  • 29. RTI-352: a 3 alpha analogue of RTI-55 as an in vivo dopamine transporter binding ligand.
    Zhan Y; Saindane AM; Scheffel U; Carroll FI; Holmquist CR; Kepler JA; Taylor GF; Kuhar MJ
    Synapse; 1997 Apr; 25(4):389-92. PubMed ID: 9097398
    [No Abstract]   [Full Text] [Related]  

  • 30. Withdrawal of repeated cocaine decreases autoradiographic [3H]mazindol-labelling of dopamine transporter in rat nucleus accumbens.
    Sharpe LG; Pilotte NS; Mitchell WM; De Souza EB
    Eur J Pharmacol; 1991 Oct; 203(1):141-4. PubMed ID: 1797552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multisubstrate kinetic mechanism of dopamine transport in the nucleus accumbens and its inhibition by cocaine.
    Povlock SL; Schenk JO
    J Neurochem; 1997 Sep; 69(3):1093-105. PubMed ID: 9282932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of kappa-opioid receptor agonists on long-term cocaine use and dopamine neurotransmission.
    Collins SL; D'Addario C; Izenwasser S
    Eur J Pharmacol; 2001 Aug; 426(1-2):25-34. PubMed ID: 11525767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postnatal development of the dopamine transporter: a quantitative autoradiographic study.
    Coulter CL; Happe HK; Murrin LC
    Brain Res Dev Brain Res; 1996 Apr; 92(2):172-81. PubMed ID: 8738124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization and quantification of the dopamine transporter: comparison of [3H]WIN 35,428 and [125I]RTI-55.
    Coulter CL; Happe HK; Bergman DA; Murrin LC
    Brain Res; 1995 Sep; 690(2):217-24. PubMed ID: 8535839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine transporter binding in rat striatum and nucleus accumbens is unaltered following chronic changes in dopamine levels.
    Moody CA; Granneman JG; Bannon MJ
    Neurosci Lett; 1996 Oct; 217(1):55-7. PubMed ID: 8905738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53-knockout mice are protected against the long-term effects of methamphetamine on dopaminergic terminals and cell bodies.
    Hirata H; Cadet JL
    J Neurochem; 1997 Aug; 69(2):780-90. PubMed ID: 9231739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of effect of chronic clorgyline or selegiline on dopamine and serotonin transporters in rat caudate-putamen or nucleus accumbens septi.
    Yeghiayan SK; Andersen SL; Baldessarini RJ
    Neurosci Lett; 1997 Nov; 236(3):147-50. PubMed ID: 9406758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postnatal development of dopamine and serotonin transporters in rat caudate-putamen and nucleus accumbens septi.
    Tarazi FI; Tomasini EC; Baldessarini RJ
    Neurosci Lett; 1998 Sep; 254(1):21-4. PubMed ID: 9780082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [125I]RTI-55: a potent ligand for dopamine transporters.
    Boja JW; Patel A; Carroll FI; Rahman MA; Philip A; Lewin AH; Kopajtic TA; Kuhar MJ
    Eur J Pharmacol; 1991 Feb; 194(1):133-4. PubMed ID: 2060590
    [No Abstract]   [Full Text] [Related]  

  • 40. Dopamine-transporter density in nucleus accumbens of type-1 alcoholics.
    Tupala E; Hall H; Särkioja T; Räsänen P; Tiihonen J
    Lancet; 2000 Jan; 355(9201):380. PubMed ID: 10665563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.